BIOQuébec and Quebec CROS on a Mission in Boston

BIOQuébec is proud to be organizing, in partnership with Investissement Québec International, the Quebec CROs mission during MassBio’s State of Possible Conference, being held from May 4 to 6.

This mission’s schedule is full and targets relevant business meetings. Participants are BIOQuébec members who will have the opportunity to meet with MassBio executives, learn more about best business practices in Boston, participate in the State of Possible Conference, MassBio’s annual meeting, and build relationships with several of the area’s businesses and venture capitalists.

These companies will be representing Quebec during this mission and will manifest our ecosystem’s vitality:

  • Banook Group

  • Corealis Pharma

  • Diex Research

  • Domain Thérapeutiques

  • Inixium

  • Modelis

  • Molecular Forecaster

  • Mispro

  • Nuchem

  • PhenoSwitch

  • Spectrum Pharma

By their active support of discovery and innovation, CROs are integral components of Quebec’s life sciences sector’s growth. Participants will have the opportunity to further develop their ties with the Massachusetts biotech industry, find partners and clients, and showcase our industry’s strengths.

NewsGuest UserBIOOQuébecMassBio, innovation, biotechnology